Session » Professional Education Poster

Date: Monday, November 9, 2020

Time: 9:00AM-11:00AM

Meeting: ACR Convergence 2020

9:00AM-11:00AM: Abstract Number: 1706

Advanced Integrated Science Courses: A Novel Approach to Medical Student Science Education

9:00AM-11:00AM: Abstract Number: 1700

Curricular Implementation of the Rheumatic Disease Patient Expert Program: The Students’ Perspective

9:00AM-11:00AM: Abstract Number: 1707

Development and Delivery of Continuing Education Interventions Promoting Shared Decision Making in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1701

Development and Validity Evidence for a Tool to Assess the Performance of Shoulder Injections

9:00AM-11:00AM: Abstract Number: 1703

Gender Equity in Academic Rheumatology – Is There a Gender Gap at European Rheumatology Congresses?

9:00AM-11:00AM: Abstract Number: 1704

Identifying Primary Care Clinician Knowledge Gaps and Needs in Rheumatologic Care for Rural Veterans

9:00AM-11:00AM: Abstract Number: 1697

Immune Related Adverse Events from Checkpoint Inhibitor Therapy: Survey of Hospitalists’ Awareness and Experiences

9:00AM-11:00AM: Abstract Number: 1712

Implementation of a Musculoskeletal Ultrasound (MSUS) Curriculum in an Academic Rheumatology Fellowship Within an Integrated Health System: A Four-Year Experience

9:00AM-11:00AM: Abstract Number: 1705

In-Person Musculoskeletal Exam Demonstration by Rheumatologist More Effective Than Virtual PowerPoint Presentation in Teaching Internal Medicine Residents

9:00AM-11:00AM: Abstract Number: 1708

Itching to Learn: Infusion Reactions Curriculum for Medicine Trainees

9:00AM-11:00AM: Abstract Number: 1696

Measuring Quality Improvement from CME Participants: Results from the RAPID® CME Initiative

9:00AM-11:00AM: Abstract Number: 1711

Musculoskeletal Sarcoidosis Learning Module for Internal Medicine Trainees: Developing a Rheumatology Curriculum

9:00AM-11:00AM: Abstract Number: 1698

Polyarthritis Workup in Primary Care Setting : How Are We Doing?

9:00AM-11:00AM: Abstract Number: 1702

RA-Related Knowledge and Skills of Rheumatology Fellows Among 20 US Academic Institutions

9:00AM-11:00AM: Abstract Number: 1710

Remote Rheumapalooza: Reboot of a Foundational Rheumatology Curriculum for Pre-Clinical Medical Students in the Era of Virtual Learning

9:00AM-11:00AM: Abstract Number: 1709

Teaching Clinical Application of Bayesian Reasoning in Rheumatology to Internal Medicine Residents and Medical Students

9:00AM-11:00AM: Abstract Number: 1699

Training Residents to ‘Choose Wisely’ When Testing for Antinuclear Antibodies

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].